(dtpa-phe(1))-octreotide and Granuloma

(dtpa-phe(1))-octreotide has been researched along with Granuloma* in 2 studies

Other Studies

2 other study(ies) available for (dtpa-phe(1))-octreotide and Granuloma

Article	Year
Buttock granulomas: a consequence of intramuscular injection of Sandostatin detected by In-111 octreoscan. Clinical nuclear medicine, 2001, Volume: 26, Issue:7 Topics: Antineoplastic Agents, Hormonal; Buttocks; Carcinoid Tumor; Female; Granuloma; Humans; Injections, Intramuscular; Middle Aged; Muscle, Skeletal; Muscular Diseases; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals	2001
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Hormone and metabolic research. Supplement series, 1993, Volume: 27 Somatostatin receptor scintigraphy with 111In-labeled octreotide was performed in 22 patients with suspected or known malignant lymphoma. The majority of extra-abdominal lesions (21/24 = 87.5%) were correctly localized, however, only one of nine intraabdominal lymphomas could be detected. No significant correlation was found between scintigraphic results and histological type of lymphoma. Metabolic imaging by positron-emission tomography with 18F-labeled deoxyglucose yielded a higher rate of detection of lymphoma manifestations (92% vs 64%) and better tumor contrast. Further prospective studies are needed to establish the clinical relevance of somatostatin receptor scintigraphy in malignant lymphoma. Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed	1993

Article

Year

Buttock granulomas: a consequence of intramuscular injection of Sandostatin detected by In-111 octreoscan.

Clinical nuclear medicine, 2001, Volume: 26, Issue:7

Topics: Antineoplastic Agents, Hormonal; Buttocks; Carcinoid Tumor; Female; Granuloma; Humans; Injections, Intramuscular; Middle Aged; Muscle, Skeletal; Muscular Diseases; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals

2001

Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.

Hormone and metabolic research. Supplement series, 1993, Volume: 27

Somatostatin receptor scintigraphy with 111In-labeled octreotide was performed in 22 patients with suspected or known malignant lymphoma. The majority of extra-abdominal lesions (21/24 = 87.5%) were correctly localized, however, only one of nine intraabdominal lymphomas could be detected. No significant correlation was found between scintigraphic results and histological type of lymphoma. Metabolic imaging by positron-emission tomography with 18F-labeled deoxyglucose yielded a higher rate of detection of lymphoma manifestations (92% vs 64%) and better tumor contrast. Further prospective studies are needed to establish the clinical relevance of somatostatin receptor scintigraphy in malignant lymphoma.

Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed

1993